Excited to share our latest work in @hrs_journal on characterization of a novel SCN5A variant causing LQT3. Phenytoin could be effective as a variant specific therapy. Thanks @MJAckermanMDPhD for the mentorship!
Functional Characterization and Identification of a Therapeutic for a Novel SCN5A-F1760C Variant Causing Type 3 Long QT Syndrome Refractory to All Guideline-Directed Therapies, by @MJAckermanMDPhD and colleagues heartrhythmjournal.com/article/S1547-…View quoted post on X
